NCT07210125Active, not recruitingPhase 4
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
Implementation and Delivery of Lenacapavir for PrEP in a Community Pharmacy Setting
Source: ClinicalTrials.gov · Last updated 2 Apr 2026
Brief summary (registry, in English)
This is an open-label, single center study to evaluate implementation of a pharmacist-managed delivery of L4P in a community pharmacy setting and the impact of twice-yearly vs. quarterly PrEP visits on STI rates.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 15 Sept 2025
- Start date
- 16 Sept 2025
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- Kelley-Ross & Associates, Inc.
- Diseases
- HIV
- NCT number
- NCT07210125
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 75
- From 16 Sept 2025 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Coadministration of drugs that significantly decreases lenacapavir concentrations according to the FDA package insert
Other illness
- Unknown or positive HIV status
Other
- Any participant that do not meet criteria for management under the CDTA
Who the study is looking for
- 18 years of age or older at the time of screening
- weight greater than or equal to 35kg
- HIV-negative status
- Willing to provide informed consent and undergo all required study procedures
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kelley-Ross Pharmacy Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.